Výsledky vyhledávání - Anne‐Marie Martin
- Zobrazuji výsledky 1 - 20 z 21
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
Screening for Genomic Rearrangements in Families with Breast and Ovarian Cancer Identifies BRCA1 Mutations Previously Missed by Conformation-Sensitive Gel Electrophoresis or Sequen... Autor Meredith A. Unger, Katherine L. Nathanson, Kathleen A. Calzone, Danielle Antin‐Ozerkis, Helen A. Shih, Anne‐Marie Martin, Gilbert Lenoir, Sylvie Mazoyer, Barbara L. Weber
Vydáno 2000Artigo -
7
The Functional Role of the Second NPXY Motif of the LRP1 β-Chain in Tissue-type Plasminogen Activator-mediated Activation of N-Methyl-D-aspartate Receptors Autor Anne Marie Martin, Christoph Kuhlmann, Svenja V. Trossbach, Sébastian Jaeger, Elaine Waldron, Anton Roebroek, Heiko J. Luhmann, A. Laatsch, Sascha Weggen, Volkmar Leßmann, Claus U. Pietrzik
Vydáno 2008Artigo -
8
α‐secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Aβ generation Autor Sebastian Jäger, Stefanie Leuchtenberger, Anne Marie Martin, Eva Czirr, Johanna Wesselowski, Marco Dieckmann, Elaine Waldron, Carsten Korth, Edward H. Koo, Michael T. Heneka, Sascha Weggen, Claus U. Pietrzik
Vydáno 2009Artigo -
9
Baseline Omega-3 Index Correlates with Aggressive and Attention Deficit Disorder Behaviours in Adult Prisoners Autor Barbara J. Meyer, Mitchell K. Byrne, Carole Collier, Natalie Parletta, Donna Crawford, Pia C. Winberg, David Webster, Karen Chapman, Gayle Thomas, Jean Dally, Marijka Batterham, Ian Farquhar, Anne‐Marie Martin, Luke Grant
Vydáno 2015Artigo -
10
Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb<sup>®</sup>, GW572016) in an expanded pane... Autor David W. Rusnak, Krystal J. Alligood, Robert J. Mullin, Glenn Spehar, Carmen P. Arenas-Elliott, Anne Marie Martin, Yan Degenhardt, Sharon K. Rudolph, Thomas F. Haws, Buffy Hudson‐Curtis, Tona M. Gilmer
Vydáno 2007Artigo -
11
Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial Autor Connie Wong, Jason Baum, Angela Silvestro, Michael T. Beste, Bharani Bharani-Dharan, Siyan Xu, Ying A. Wang, Xiaoshan Wang, Margaret F. Prescott, Lynne Krajkovich, Margaret Dugan, Paul M. Ridker, Anne‐Marie Martin, E. C. Svensson
Vydáno 2020Artigo -
12
Correlation of <i>BRAF</i> Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials Autor Ademi Santiago-Walker, Robert Gagnon, Jolly Mazumdar, Michelle Casey, Georgina V. Long, Dirk Schadendorf, Keith T. Flaherty, Richard Kefford, Axel Hauschild, Patrick Hwu, Patricia Haney, Anne O’Hagan, Jennifer Carver, Vicki Goodman, Jeffrey J. Legos, Anne‐Marie Martin
Vydáno 2015Artigo -
13
HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer Autor Michael F. Press, Richard S. Finn, David Cameron, Angelo Di Leo, Charles E. Geyer, Ivonne Villalobos, Angela Santiago, Roberta Guzman, Armen Yuri Gasparyan, Yanling Ma, K. D. Danenberg, Anne Marie Martin, Lisa Williams, Cristina Oliva, Steven Stein, Robert Gagnon, Michael Arbushites, María Koehler
Vydáno 2008Artigo -
14
Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer Autor Manish A. Shah, Zev A. Wainberg, Daniel V.T. Catenacci, Howard S. Höchster, James M. Ford, Pamela L. Kunz, Fa-Chyi Lee, Howard Kallender, Franco Cecchi, Daniel C. Rabe, Harold Keer, Anne‐Marie Martin, Yuan Liu, Robert Gagnon, Peter L. Bonate, Li Liu, Tona M. Gilmer, Donald P. Bottaro
Vydáno 2013Artigo -
15
Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436) Autor Katherine L. Nathanson, Anne‐Marie Martin, Bradley Wubbenhorst, Joel Greshock, Richard Letrero, Kurt D’Andrea, Steven O’Day, Jeffrey R. Infante, Gerald S. Falchook, Hendrik‐Tobias Arkenau, Michael Millward, Michael P. Brown, Anna C. Pavlick, Michael A. Davies, Bo Ma, Robert Gagnon, Martin Curtis, Peter F. Lebowitz, Richard Kefford, Georgina V. Long
Vydáno 2013Artigo -
16
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma Autor Keith T. Flaherty, Caroline Robert, Peter Hersey, Paul Nathan, Claus Garbe, Mohammed Milhem, Lev Demidov, Jessica C. Hassel, Piotr Rutkowski, Peter Mohr, Reinhard Dummer, Uwe Trefzer, James Larkin, Jochen Utikal, Brigitte Dréno, Marta Nyakas, Mark R. Middleton, Jürgen C. Becker, Michelle Casey, Laurie Sherman, Frank Wu, Danièle Ouellet, Anne‐Marie Martin, Kiran Klaus Patel, Dirk Schadendorf
Vydáno 2012Artigo -
17
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib Autor Caroline Robert, Bogusława Karaszewska, Jacob Schachter, Piotr Rutkowski, Andrzej Maćkiewicz, D. Stroiakovski, M. Lichinitser, Reinhard Dummer, Florent Grange, Laurent Mortier, Vanna Chiarion‐Sileni, Kamil Drucis, Ivana Krajsová, Axel Hauschild, Paul Lorigan, Pascal Wolter, Georgina V. Long, Keith T. Flaherty, Paul Nathan, Antoni Ribas, Anne-Marie Martin, Peng Sun, Wendy Crist, Jeff Legos, Stephen D. Rubin, Shonda M Little, Dirk Schadendorf
Vydáno 2014Artigo -
18
Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses Autor Rohan Diwanji, Neil A. O’Brien, Jiyoung E. Choi, Beverly Nguyen, Tyler Laszewski, Angelo L. Grauel, Zheng Yan, Xin Xu, Jincheng Wu, David A. Ruddy, Michelle Piquet, Marc R. Pelletier, Alexander Savchenko, LaSalette Charette, Vanessa Rodrik-Outmezguine, Jason Baum, John M. Millholland, Connie Wong, Anne-Marie Martin, Glenn Dranoff, Iulian Pruteanu-Malinici, Viviana Cremasco, Catherine Sabatos-Peyton, Pushpa Jayaraman
Vydáno 2023Artigo -
19
Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma Autor Jessie Villanueva, Jeffrey R. Infante, Clemens Krepler, Patricia Reyes-Uribe, Minu Samanta, Hsin‐Yi Chen, Bin Li, Rolf Swoboda, Melissa Wilson, Adina Vultur, Mizuho Fukunaba-Kalabis, Bradley Wubbenhorst, Thomas Y. Chen, Qin Liu, Katrin Sproesser, Douglas J. DeMarini, Tona M. Gilmer, Anne‐Marie Martin, Ronen Marmorstein, D. Schultz, David W. Speicher, Giorgos C. Karakousis, Wei Xu, Ravi K. Amaravadi, Xiaowei Xu, Lynn M. Schuchter, Meenhard Herlyn, Katherine L. Nathanson
Vydáno 2013Artigo -
20
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma Autor Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas, E. Levchenko, Filippo de Braud, James Larkin, Claus Garbe, Thomas Jouary, Axel Hauschild, Jean‐Jacques Grob, Vanna Chiarion‐Sileni, Célèste Lebbé, Mario Mandalà, Michael Millward, Ana Arance, Igor Bondarenko, John B.A.G. Haanen, Johan Hansson, Jochen Utikal, Virginia Ferraresi, Н. В. Коваленко, Peter Mohr, Volodymyr Probachai, Dirk Schadendorf, Paul Nathan, Caroline Robert, Antoni Ribas, Douglas J. DeMarini, Jhangir G Irani, Michelle Casey, Danièle Ouellet, Anne‐Marie Martin, Ngocdiep T. Le, Kiran Patel, Keith T. Flaherty
Vydáno 2014Artigo
Vyhledávací nástroje:
Související témata
Biology
Medicine
Cancer
Internal medicine
Cancer research
Oncology
Genetics
Dabrafenib
Gene
Kinase
MAPK/ERK pathway
Melanoma
Metastatic melanoma
Trametinib
Vemurafenib
Cell biology
Breast cancer
Mutation
Receptor
Adverse effect
Biochemistry
Cell
Chemistry
Computer science
Confidence interval
Hazard ratio
Lapatinib
Trastuzumab
Cell culture
Chromosome